Physician profile
James L Head
NPI 1740324086
$6,317.49
in general payments reported to CMS, 2019-2025
40 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,123 · 2020: $553 · 2021: $676 · 2022: $676 · 2023: $518 · 2024: $504 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,697.60 | 2019-2020 | |
| Abbvie INC. | $632.23 | 2019-2024 | |
| Medtronic, INC. | $413.08 | 2022-2025 | Interstim |
| Astellas Pharma US INC | $393.30 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $200.51 | 2023-2025 | |
| Hologic Sales and Service, LLC | $174.86 | 2019-2025 | Aptima |
| Roche Diagnostics Corporation | $136.32 | 2019-2021 | |
| Amgen INC. | $130.71 | 2019-2021 | |
| Caldera Medical, INC | $123.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.97 | 2019-2024 | |
| Scynexis, INC. | $115.33 | 2021-2022 | |
| Therapeuticsmd, INC. | $109.79 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $95.51 | 2023-2024 | Gemtesa, Myfembree |
| Novo Nordisk INC | $86.78 | 2022-2024 | Wegovy |
| Pfizer INC. | $85.17 | 2023-2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $82.00 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $77.36 | 2020-2022 | |
| Organon LLC | $67.10 | 2022-2023 | Nexplanon |
| Urovant Sciences INC | $66.83 | 2022 | |
| Conmed Corporation | $65.52 | 2023-2024 | Airseal, Vcare |
| Axonics, INC. | $46.85 | 2021-2023 | Axonics |
| Boston Scientific Corporation | $43.38 | 2019-2021 | |
| Intuitive Surgical, INC. | $39.10 | 2023 | Da Vinci Surgical System |
| Exeltis, USA INC. | $35.91 | 2020-2022 | |
| Ethicon US, LLC | $28.03 | 2024 | Ethicon |
| Biohaven Pharmaceutical Holding Company LTD. | $24.28 | 2022 | |
| Allergan, INC. | $23.58 | 2019-2021 | |
| Meditrina | $23.48 | 2022 | |
| Davol INC. | $20.85 | 2020 | |
| Agile Therapeutics, INC. | $17.21 | 2021 | |
| Shield Therapeutics INC | $17.01 | 2025 | |
| Monaghan Medical Corporation | $16.64 | 2023 | Aeroeclipse |
| Minerva Surgical, INC | $16.54 | 2023 | |
| Sage Therapeutics, LLC | $16.05 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $15.72 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.18 | 2019 | |
| Coloplast Corp | $12.54 | 2019 | |
| Myovant Sciences INC. | $12.06 | 2021 | |
| Merck Sharp & Dohme LLC | $12.00 | 2019 | |
| Lupin INC. | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Head listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.